Not Yet RecruitingNot Applicable

No Stoma VS Ghost Stoma in Patients Undergoing Total Mesorectal Excision for Rectal Cancer

500 participantsStarted 2024-03-01

Plain-language summary

This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy group versus no ileostomy group after total mesorectal excision for rectal cancer.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pathologically confirmed rectal cancer. * age ≥18 years and ≤80 years. * intraoperative ghost ileostomy or no stoma was performed. Exclusion Criteria: * ASA score \>3. * Patients with coexisting complete intestinal obstruction. * History of long-term use of immunosuppressive drugs or glucocorticoids. * Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. * Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure. * chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/min). Intraoperative combined multi-organ resection. * Combined cirrhosis of the liver. * Intraoperative findings of incomplete anastomosis and positive insufflation test.

What they're measuring

Calculation postoperative of the Comprehensive Complication Index (CCI) for each patient

Timeframe: An average of 1 year from the date of total mesorectal excision for rectal cancer until the date of when the patient's condition is stabilized without complications

Trial details

NCT IDNCT06225609

Sponsorfan li

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Rectal Neoplasms trials